Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Georg Buchner

Premium

Silence Therapeutics has named Georg Buchner as vice president of business development.

In this role, he will work with the company's chief business officer to broaden its collaborations with pharmaceutical and biotech firms.

He previously served as vice president of corporate and business development at Novacta Biosystems.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.